Literature DB >> 313860

Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

R L Gonzalez, P C Dau, L E Spitler.   

Abstract

Suppression of the lymphocyte response to concanavalin A (Con A), phytohaemagglutinin (PHA) and protein A from Staphylococcus aureus (SpA) by Con A-induced suppressor cells was measured in twenty-four patients with recently active-recovering multiple sclerosis (MS), twelve with inactive MS and twenty-three healthy controls. Patients with recently active disease displayed significantly greater suppression of the response to Con A. Suppression of the responses to PHA and SpA did not differ among the groups. Lymphocyte stimulation in cultures not showing suppression was similar in all three types of subjects. These results suggest a disturbance of lymphocyte regulation in patients with recently active-recovering MS and illustrate the potential usefulness of measuring the suppression of responsiveness to several mitogens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313860      PMCID: PMC1537686     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Concanavalin A-activated suppressor cells in normal human peripheral blood lymphocytes.

Authors:  C Hubert; G Delespesse; A Govaerts
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

2.  Selective responses of mouse T lymphocytes to different T mitogens and in mixed lymphocyte culture induced cytolysis reaction.

Authors:  P Häyry; P J Roberts; A Ranki; T Weber
Journal:  Cell Immunol       Date:  1976-07       Impact factor: 4.868

3.  Protein A from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

5.  Imbalances in T cell subpopulations in multiple sclerosis patients.

Authors:  D Santoli; L Moretta; R Lisak; D Gilden; H Koprowski
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

6.  Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium.

Authors:  S Horowitz; W Borcherding; A V Moorthy; R Chesney; H Schulte-Wisserman; R Hong
Journal:  Science       Date:  1977-09-02       Impact factor: 47.728

Review 7.  Humoral factors involved in immune processes in multiple sclerosis and allergic encephalomyelitis.

Authors:  E A Caspary
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

8.  Immunoglobulin-containing cells in multiple-sclerosis plaques.

Authors:  M M Esiri
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

9.  The polyclonal B-cell-activating property of protein A is not due to its interaction with the FC part of immunoglobulin receptors.

Authors:  G Möller; P Landwall
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

3.  Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease.

Authors:  J Merrill; M Jondal; J Seeley; M Ullberg; A Sidén
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

4.  Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis.

Authors:  J Antel; J J Oger; S Jackevicius; H H Kuo; B G Arnason
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Modifying the biological response in acute myeloid leukemia. II. Effect of BCG and leukemic cells on lymphocyte response to mitogens, and on helper and suppressor activity.

Authors:  A Arends-Merino; R Giscombe; C Ogier; P Reizenstein; A M Sjörgen; J Wasserman
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.

Authors:  J C Craig; S A Hawkins; M W Swallow; J A Lyttle; V H Patterson; J D Merrett; M Haire
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

7.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis.

Authors:  M Zaffaroni; D Caputo; A Ghezzi; S Marforio; C L Cazzullo
Journal:  Ital J Neurol Sci       Date:  1984-03

9.  Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression.

Authors:  C G Kallenberg; G C de Gast; T H The
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

10.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.